Methylnaltrexone bromide, an antagonist of the µ-opioid receptor, reduces the viability of lung cancer cells by inhibiting Src activation.

 

Brand: BCM

 

Target: Opioid Receptor

 

Signaling Pathways: Endocrinology/Hormones; GPCR/G Protein; Neuroscience

 

Melting Point: 237-239°C

 

Solubility: Soluble in DMSO; soluble in Water. Insoluble in Ethanol.

 

Stability: Hygroscopic

 

GHS: GHS06, GHS09

 

Isomeric SMILES: C[N+]1(CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)O)O4)O)CC6CC6.[Br-]  

 

InChIKey: IFGIYSGOEZJNBE-KNLJMPJLSA-N  

 

InChI: InChI=1S/C21H25NO4.BrH/c1-22(11-12-2-3-12)9-8-20-17-13-4-5-14(23)18(17)26-19(20)15(24)6-7-21(20,25)16(22)10-13;/h4-5,12,16,19,25H,2-3,6-11H2,1H3;1H/t16-,19+,20+,21-,22?;/m1./s1

 

Attribute
[Chem Name]	(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-3-ium-7-one;bromide
[Synonym]	Methylnaltrexone bromide
[CAS No.]	73232-52-7
[MDL No.]	MFCD06407831
[Formula]	C21H26BrNO4
[Molecular]	436.35
[Form]	white to beige powder
[Storage]	-20°C

Goods Tag